Abstract

Background: Paroxysmal sympathetic hyperactivity (PSH) is one of the important reasons for the high mortality and morbidity of traumatic brain injury (TBI). We aim to explore the role of the neutrophil extracellular traps (NETs) in the pathogenesis of sympathetic hyperexcitability after TBI and the underlying mechanisms, providing evidence for clinical treatment.Methods: Enzyme-linked immunosorbent assay was used to assess the plasma metanephrine and normetanephrine levels which represented the variation of the sympathetic system after TBI with rat diffuse axonal injury (DAI) model. NETs in the paraventricular nucleus (PVN) and circulating blood were examined using immunofluorescence and flow cytometry. Neutrophils-microglia co-culture system was established to further explore the effect of NETs on PSH and its mechanisms.Results: After TBI, metanephrine and normetanephrine levels began to increase at 9 h and peaked at 72 h. After the injury, the level of NETs kept increasing at 24 and 72 h in the PVN. A positive correlation was found between the concentration of the PVN NETs and blood catecholamine. Flow cytometry of peripheral blood cells revealed that NETs level in the injury group was higher than that in the control group. Immunofluorescence results confirmed the presence of NETs in the PVN after TBI. The positive result of immunoprecipitation suggested a correlation effect between LL37 and P2 × 7. Peptidyl arginine deiminase-4 (PAD4) inhibitor could inhibit the expression levels of MST1, YAP, and IL-1β. The hippo/MST1 pathway inhibitor could inhibit the expression levels of YAP and IL-1β.Conclusion: NETs formation in the PVN might be associated with sympathetic hyperactivity after TBI, which might relate to the activation of microglia cells and increased secretion of IL-1β via the hippo/MST1 pathway.

Highlights

  • There are more than 60 million new cases of traumatic brain injury (TBI) each year, and the incidence rate is still increasing year over year (Dewan et al, 2018)

  • The results showed that Citrullinated histone H3 (CitH3) appeared in the paraventricular nucleus (PVN) about 24 h after diffuse axonal injury (DAI) injury, and the level of CitH3 kept increasing at 72 h with a subsequent upward trend (Figures 2A,B)

  • We firstly proved the existence of neutrophil extracellular traps (NETs) in the PVN after TBI and examined its effects on the sympathetic hyperactivity

Read more

Summary

Introduction

There are more than 60 million new cases of traumatic brain injury (TBI) each year, and the incidence rate is still increasing year over year (Dewan et al, 2018). Paroxysmal sympathetic hyperactivity (PSH) is often secondary to TBI, accounting for about 8–33% of TBI patients (Bueno González et al, 2014). It is mainly manifested as paroxysmal hyperexcitability of the sympathetic nervous system and abnormal motor system and its clinical symptoms include tachycardia, tachypnea, diaphoresis, fever, hypertension, and dystonic posturing (Hasen et al, 2019). PSH is one of the main reasons for the high mortality and morbidity of TBI (Meyfroidt et al, 2017). Paroxysmal sympathetic hyperactivity (PSH) is one of the important reasons for the high mortality and morbidity of traumatic brain injury (TBI). We aim to explore the role of the neutrophil extracellular traps (NETs) in the pathogenesis of sympathetic hyperexcitability after TBI and the underlying mechanisms, providing evidence for clinical treatment

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.